KP
Kaveri Pohlman Clear Street Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
ArriVent BioPharma
AVBP
$772M
| $19.02 | $32 |
68%
upside
| Buy |
25 Jun ‘25
2 months ago |
|
2
Genmab
GMAB
$17.6B
| $28.61 | $47 |
64%
upside
| Buy |
27 Jun ‘24
1 year ago |
|
3
Cullinan Oncology
CGEM
$391M
| $6.62 | $30 |
353%
upside
| Buy |
17 Apr ‘24
1 year ago |
|
4
Xencor
XNCR
$606M
| $8.50 | $38 |
347%
upside
| Buy |
16 Apr ‘24
1 year ago |
|
5
Nuvation Bio
NUVB
$1.15B
| $3.35 | $5 |
49%
upside
| Buy |
26 Mar ‘24
1 year ago |
|
6
Janux Therapeutics
JANX
$1.51B
| $25.12 | $62 |
147%
upside
| Buy |
21 Mar ‘24
1 year ago |
|
7
Pyxis Oncology
PYXS
$115M
| $1.86 | $8 |
330%
upside
| Buy |
9 Feb ‘24
1 year ago |
|
8
Exelixis
EXEL
$10.5B
| $39.07 | $27 |
31%
downside
| Buy |
19 Dec ‘23
1 year ago |
|
9
Arcus Biosciences
RCUS
$1.22B
| $11.50 | $70 |
509%
upside
| Buy |
23 Aug ‘23
2 years ago |
|
10
Shattuck Labs
STTK
$94.8M
| $1.98 | $12 |
506%
upside
| Buy |
31 Aug ‘22
3 years ago |
|
11
CytomX Therapeutics
CTMX
$345M
| $2.09 | $8 |
283%
upside
| Buy |
7 Jul ‘22
3 years ago |
|
12
Sonnet BioTherapeutics
SONN
$27M
| $3.96 | $4,928 |
124,344%
upside
| Buy |
9 Feb ‘22
3 years ago |
|